Literature DB >> 16195254

Surveillance for resistance to metronidazole and vancomycin in genotypically distinct and UK epidemic Clostridium difficile isolates in a large teaching hospital.

Jane Freeman, Joanna Stott, Simon D Baines, Warren N Fawley, Mark H Wilcox.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16195254     DOI： 10.1093/jac/dki357

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  11 in total

1.  Can metronidazole still be used for treatment of Clostridium difficile infections?

Authors:  Haihui Huang; Carl Erik Nord
Journal:  Curr Infect Dis Rep       Date:  2009-01       Impact factor: 3.725

Review 2.  Recent advances in the understanding of antibiotic resistance in Clostridium difficile infection.

Authors:  Patrizia Spigaglia
Journal:  Ther Adv Infect Dis       Date:  2016-02

Review 3.  Clostridium difficile-associated disease: changing epidemiology and implications for management.

Authors:  Robert C Owens
Journal:  Drugs       Date:  2007       Impact factor: 9.546

4.  Genome Location Dictates the Transcriptional Response to PolC Inhibition in Clostridium difficile.

Authors:  Erika van Eijk; Ilse M Boekhoud; Ed J Kuijper; Ingrid M J G Bos-Sanders; George Wright; Wiep Klaas Smits
Journal:  Antimicrob Agents Chemother       Date:  2019-01-29       Impact factor: 5.191

5.  Faecal pharmacokinetics of orally administered vancomycin in patients with suspected Clostridium difficile infection.

Authors:  Milagros Gonzales; Jacques Pepin; Eric H Frost; Julie C Carrier; Stephanie Sirard; Louis-Charles Fortier; Louis Valiquette
Journal:  BMC Infect Dis       Date:  2010-12-30       Impact factor: 3.090

6.  Proteomic analysis of a NAP1 Clostridium difficile clinical isolate resistant to metronidazole.

Authors:  Patrick M Chong; Tarah Lynch; Stuart McCorrister; Pamela Kibsey; Mark Miller; Denise Gravel; Garrett R Westmacott; Michael R Mulvey
Journal:  PLoS One       Date:  2014-01-06       Impact factor: 3.240

7.  Vancomycin Enemas as Adjunctive Therapy for Clostridium difficile Infection.

Authors:  Mark Malamood; Eric Nellis; Adam C Ehrlich; Frank K Friedenberg
Journal:  J Clin Med Res       Date:  2015-04-08

8.  A DNA vaccine targeting TcdA and TcdB induces protective immunity against Clostridium difficile.

Authors:  Bao-Zhong Zhang; Jianpiao Cai; Bin Yu; Yanhong Hua; Candy Choiyi Lau; Richard Yi-Tsun Tsun Kao; Kong-Hung Sze; Kwok-Yung Yuen; Jian-Dong Huang
Journal:  BMC Infect Dis       Date:  2016-10-22       Impact factor: 3.090

Review 9.  Conventional and alternative treatment approaches for Clostridium difficile infection.

Authors:  Khalid M Aljarallah
Journal:  Int J Health Sci (Qassim)       Date:  2017 Jan-Mar

Review 10.  Clostridium difficile Infections: A Global Overview of Drug Sensitivity and Resistance Mechanisms.

Authors:  Saeed S Banawas
Journal:  Biomed Res Int       Date:  2018-02-21       Impact factor: 3.411
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.